(Q28369383)

English

In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives (English)

0 references

author name string

K Fujii

series ordinal

1

0 references

A Tsuji

series ordinal

2

0 references

S Miyazaki

series ordinal

3

0 references

K Yamaguchi

series ordinal

4

0 references

S Goto

series ordinal

5

0 references

language of work or name

English

0 references

publication date

May 1994

0 references

published in

Antimicrobial Agents and Chemotherapy

0 references

volume

38

0 references

issue

5

0 references

page(s)

1118-22

0 references

cites work

In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188160

retrieved

20 March 2017

Therapeutic efficacy of the benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188160

retrieved

20 March 2017

In vitro activities of new rifamycin derivatives against Mycobacterium tuberculosis and M. avium complex

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188160

retrieved

20 March 2017

In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188160

retrieved

20 March 2017

In vivo activities of new rifamycin derivatives against mycobacteria

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188160

retrieved

20 March 2017

Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188160

retrieved

20 March 2017

Combination antibiotic therapy of bacterial endocarditis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188160

retrieved

29 September 2017

Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188160

retrieved

2 June 2018

Differences in ability of cell-wall antibiotics to suppress emergence of rifampicin resistance in Staphylococcus aureus.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188160

retrieved

27 November 2018

Identifiers

DOI

10.1128/AAC.38.5.1118

0 references

PMC publication ID

188160

0 references

PubMed publication ID

8067748

0 references

(Q28369383)

In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)